Imelda

At Imelda in Bonheiden, Belgium, the Cardiology department is running a broad set of studies in cardiovascular diseases, hypertension, heart failure, and atherosclerotic cardiovascular disease. These trials are designed to test new therapies, improve risk reduction strategies, and better understand how to prevent major heart and vascular complications.

• Evaluating treatments for heart failure, acute myocardial infarction, and broader cardiovascular disease
• Studying approaches to lower blood pressure and reduce cardiovascular risk
• Testing therapies aimed at preventing major events such as stroke, heart attack, and worsening kidney-related heart disease

Several projects also focus on protecting patients with combined cardiorenal disease and inflammation, reflecting a strong interest in long-term prevention and treatment effectiveness.

A major part of the research portfolio centers on digestive system diseases, especially Crohn’s disease, ulcerative colitis, and other forms of inflammatory bowel disease. These studies aim to refine treatment targets, assess symptom control, and improve endoscopic and long-term disease outcomes.

• Testing newer therapies for Crohn’s disease and ulcerative colitis
• Comparing treatment strategies to improve clinical remission and mucosal healing
• Studying ways to reduce postoperative recurrence and support durable disease control

The research at Imelda also includes long-term follow-up studies, showing a strong commitment to understanding how patients respond over time.

The site is involved in multiple studies across neoplasms, with a particular focus on colorectal cancer, pancreatic cancer, gastric cancer, and biliary tract cancer. These trials are mainly aimed at assessing new cancer treatments, combinations of therapies, and strategies to improve survival and disease control.

• Investigating treatment options for metastatic colorectal cancer and advanced pancreatic ductal adenocarcinoma
• Evaluating new approaches for gastric and biliary tract cancers
• Assessing whether novel cancer therapies can improve progression-free survival and overall survival

This oncology work highlights both advanced disease treatment and earlier-stage strategies intended to improve outcomes after diagnosis.

Immune system diseases, musculoskeletal diseases, and nervous system diseases are also represented, including rheumatoid arthritis, multiple sclerosis, and related inflammatory conditions. The studies in these areas focus on controlling disease activity, reducing disability, and finding more effective long-term treatment plans.

• Assessing treatment adjustment strategies for rheumatoid arthritis
• Studying therapies for secondary progressive multiple sclerosis
• Exploring improved control of chronic immune-mediated inflammation

These trials reflect a practical focus on everyday disease burden, with attention to both symptom relief and lasting patient benefit.

Research at the site also spans nutritional and metabolic diseases and female urogenital diseases and pregnancy complications, including type 2 diabetes, obesity, chronic kidney disease, and fertility problems. The goal is to evaluate treatments that improve metabolic health, slow kidney disease, and support reproductive outcomes.

• Testing therapies for obesity, overweight, and type 2 diabetes
• Studying ways to slow progression of chronic kidney disease and related complications
• Evaluating fertility-related care for women with subfertility and other reproductive concerns

Together, these trials show a wide-ranging interest in prevention, chronic disease management, and improving quality of life across several interconnected fields.